Real-time enrollment status for this smoldering myeloma clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 9:38 AM UTC
| NCT Number | NCT03937635 |
| Recruiting Status | Recruiting |
| Condition | Smoldering Myeloma |
| Phase | PHASE3 |
| Target Enrollment | 288 participants |
| Active Locations | 742 sites in the US |
| Sponsor | ECOG-ACRIN Cancer Research Group |
| Last Updated on CT.gov | August 19, 2026 (1 week ago) |
As of August 31, 2026: Clinical trial NCT03937635 is currently recruiting participants. This phase3 study for smoldering myeloma is actively seeking new participants at 742 locations across the United States. The study is sponsored by ECOG-ACRIN Cancer Research Group. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03937635 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 742 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03937635 was last updated 1 week ago (August 19, 2026). HelloStudys verifies this status automatically.